Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab
Crossref DOI link: https://doi.org/10.1007/s00277-002-0581-1
Published Online: 2018-01-10
Published Print: 2003-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Herold, M.
Dölken, G.
Fiedler, F.
Franke, A.
Freund, M.
Helbig, W.
Pasold, R.
Text and Data Mining valid from 2003-02-01